From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

BREAKING: Zenith is this document a forgery or has the company misled investors on an industrial scale?

By Tom Winnifrith | Thursday 6 August 2020


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


The last time i had an article to write on Zenith Energy (ZEN) I made the mistake of contacting the company via a PR and was bullied and harassed as a result. So this time as I receive, via Winnileaks, a document which appears to show that it lost its only real asset, Tilapia in the Republic of the Congo, on June 4th, I just publish it in full. I have asked my daughter Olaf to translate it for me which – through her usual hangover – she did over the phone and it reads appallingly for Zenith. It looks kosher to me so there are only three scenarios here:

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Sunday »

Quiz

The ShareProphets Sunday Pub Quiz #272

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 12:19:11